Michele Ann Oleksak, MD | |
116 Main Street, Elderton, PA 15736-0148 | |
(724) 354-5258 | |
(724) 354-4396 |
Full Name | Michele Ann Oleksak |
---|---|
Gender | Female |
Speciality | Family Practice |
Experience | 20 Years |
Location | 116 Main Street, Elderton, Pennsylvania |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1639361975 | NPI | - | NPPES |
MD429722 | Other | PA | MEDICAL LICENSE |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Q00000X | Family Medicine | MD429722 (Pennsylvania) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Acmh Hospital | Kittanning, PA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Philip A Gelacek Md Pc | 1850300757 | 5 |
News Archive
Two scientists from Wake Forest School of Medicine, part of Wake Forest Baptist Health, have received a total of $1.5 million in research funding from the American Cancer Society to study new chemotherapy and immunotherapy treatments for cancer.
Researchers led by Regenstrief Institute investigator Neale Chumbler, Ph.D., a research scientist with the Center of Excellence on Implementing Evidence-Based Practice at the Richard Roudebush VA Medical Center in Indianapolis, have developed STeleR, a home telerehabilitation program that they report improves lower body physical functioning after a stroke.
Although survival rates for people who suffer cardiac arrest outside a hospital are extremely low in most places, emergency physicians propose three interventions to improve survival rates and functional outcomes in any community and urge additional federal funding for cardiac resuscitation research in an editorial published online last Wednesday in Annals of Emergency Medicine ("IOM Says Times to Act to Improve Cardiac Arrest Survival ... Here's How").
Writing in the Huffington Post's "The Big Push" blog, Dirk Niebel, Germany's federal minister of economic cooperation and development, discusses "why Germany announced last week that it is committing one billion euros over five years to the Global Fund."
Ikano Therapeutics, Inc. announced today that it has received Orphan Drug designation for midazolam in the acute treatment of certain forms of epileptic seizure known as cluster seizures or alternatively, as acute repetitive seizures.
› Verified 5 days ago
Entity Name | Armstrong County Memorial Hospital |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1568577724 PECOS PAC ID: 9335051663 Enrollment ID: O20031104000468 |
News Archive
Two scientists from Wake Forest School of Medicine, part of Wake Forest Baptist Health, have received a total of $1.5 million in research funding from the American Cancer Society to study new chemotherapy and immunotherapy treatments for cancer.
Researchers led by Regenstrief Institute investigator Neale Chumbler, Ph.D., a research scientist with the Center of Excellence on Implementing Evidence-Based Practice at the Richard Roudebush VA Medical Center in Indianapolis, have developed STeleR, a home telerehabilitation program that they report improves lower body physical functioning after a stroke.
Although survival rates for people who suffer cardiac arrest outside a hospital are extremely low in most places, emergency physicians propose three interventions to improve survival rates and functional outcomes in any community and urge additional federal funding for cardiac resuscitation research in an editorial published online last Wednesday in Annals of Emergency Medicine ("IOM Says Times to Act to Improve Cardiac Arrest Survival ... Here's How").
Writing in the Huffington Post's "The Big Push" blog, Dirk Niebel, Germany's federal minister of economic cooperation and development, discusses "why Germany announced last week that it is committing one billion euros over five years to the Global Fund."
Ikano Therapeutics, Inc. announced today that it has received Orphan Drug designation for midazolam in the acute treatment of certain forms of epileptic seizure known as cluster seizures or alternatively, as acute repetitive seizures.
› Verified 5 days ago
Entity Name | Philip A Gelacek Md Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1205986296 PECOS PAC ID: 1850300757 Enrollment ID: O20060420000059 |
News Archive
Two scientists from Wake Forest School of Medicine, part of Wake Forest Baptist Health, have received a total of $1.5 million in research funding from the American Cancer Society to study new chemotherapy and immunotherapy treatments for cancer.
Researchers led by Regenstrief Institute investigator Neale Chumbler, Ph.D., a research scientist with the Center of Excellence on Implementing Evidence-Based Practice at the Richard Roudebush VA Medical Center in Indianapolis, have developed STeleR, a home telerehabilitation program that they report improves lower body physical functioning after a stroke.
Although survival rates for people who suffer cardiac arrest outside a hospital are extremely low in most places, emergency physicians propose three interventions to improve survival rates and functional outcomes in any community and urge additional federal funding for cardiac resuscitation research in an editorial published online last Wednesday in Annals of Emergency Medicine ("IOM Says Times to Act to Improve Cardiac Arrest Survival ... Here's How").
Writing in the Huffington Post's "The Big Push" blog, Dirk Niebel, Germany's federal minister of economic cooperation and development, discusses "why Germany announced last week that it is committing one billion euros over five years to the Global Fund."
Ikano Therapeutics, Inc. announced today that it has received Orphan Drug designation for midazolam in the acute treatment of certain forms of epileptic seizure known as cluster seizures or alternatively, as acute repetitive seizures.
› Verified 5 days ago
Mailing Address | Practice Location Address |
---|---|
Michele Ann Oleksak, MD Po Box 579, Kittanning, PA 16201-0579 Ph: (724) 543-8164 | Michele Ann Oleksak, MD 116 Main Street, Elderton, PA 15736-0148 Ph: (724) 354-5258 |
News Archive
Two scientists from Wake Forest School of Medicine, part of Wake Forest Baptist Health, have received a total of $1.5 million in research funding from the American Cancer Society to study new chemotherapy and immunotherapy treatments for cancer.
Researchers led by Regenstrief Institute investigator Neale Chumbler, Ph.D., a research scientist with the Center of Excellence on Implementing Evidence-Based Practice at the Richard Roudebush VA Medical Center in Indianapolis, have developed STeleR, a home telerehabilitation program that they report improves lower body physical functioning after a stroke.
Although survival rates for people who suffer cardiac arrest outside a hospital are extremely low in most places, emergency physicians propose three interventions to improve survival rates and functional outcomes in any community and urge additional federal funding for cardiac resuscitation research in an editorial published online last Wednesday in Annals of Emergency Medicine ("IOM Says Times to Act to Improve Cardiac Arrest Survival ... Here's How").
Writing in the Huffington Post's "The Big Push" blog, Dirk Niebel, Germany's federal minister of economic cooperation and development, discusses "why Germany announced last week that it is committing one billion euros over five years to the Global Fund."
Ikano Therapeutics, Inc. announced today that it has received Orphan Drug designation for midazolam in the acute treatment of certain forms of epileptic seizure known as cluster seizures or alternatively, as acute repetitive seizures.
› Verified 5 days ago
Dr. Joseph A Cippel, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 116 Main St, Elderton, PA 15736 Phone: 724-354-5258 Fax: 724-354-4396 |